MedTrace Logo

Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes

NCT03714451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-02-14

No results posted yet for this study

Summary

To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).

Conditions

  • Diabetes Type 2

Interventions

DIETARY_SUPPLEMENT

onyx sorghum

The diet intervention will last a total of 28 days. Per the American Heart Association (AHA) and American Diabetes Association (ADA) recommendations, the daily diet plan will consist of 50-55% carbohydrate, 15-20% protein, and 25-30% fat. In the Onyx Group, 25% of carbohydrate will come from the onyx sorghum, and at least three foods per day (including cereals, bread, muffins, pasta, and smoothie boosters) will contain this.

DIETARY_SUPPLEMENT

whole wheat flour

Per the American Heart Association (AHA) and American Diabetes Association (ADA) recommendations, the daily diet plan will consist of 50-55% carbohydrate, 15-20% protein, and 25-30% fat.

Sponsors & Collaborators

  • Silver Palate Kitchens Inc.

    collaborator UNKNOWN

  • Yale University

    lead OTHER

Principal Investigators

  • Renata Belfort de Aguiar, MD, PhD · Yale School of Medicine Department of Endocrinology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2022-12-20
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03714451 on ClinicalTrials.gov